Loading...

INDOUS Indo US Bio-Tech Ltd Litigation, disputes or regulatory action Announcement

nd S

NDS

Indo US Bio-Tech Ltd

(INDOUS)

2025 Announcement

Regulatory Compliance

Trading Window Closure

Clarification on price move...

Reg 29(2 disclosure)

Reg 29(2) Disclosure

Promoter/Promoter group acq...

SAST Disclosure

SAST disclosure

SEBI SAST disclosure

Newspaper Publication

Financial results for the p...

Unaudited quarterly results

Trading Window Closure

Conference Participation

Newspaper Publication

Unaudited quarterly results

Unaudited financial results

Auditor Appointment

Board Meeting Notice

Postal Ballot Notice

Board Meeting Outcome

Compliance Certificate

AGM Notice Published

Financial Results Published

Price Movement Clarification

Compliance Certificate

Non Applicability Notice

Annual Compliance Report

Financial Results Published

Compliance Certificate

Promoter's Shanghai Visit

Promoter's Trip

Promoters Abroad Trip

Financial Results Announcement

Compliance Certificate

Board Committee Changes

Capital Structure Update

Audit Committee Reconstitution

Postal Ballot Notice

Financial Results Released

Dividend Announcement

Compliance Certificate

Trading Approval Granted

Award Recognition

20th AGM Notice

Migration Approval

Financial Results Published

Certificate Submission

Error Clarification

Secretarial Compliance Repo...

Annual Compliance Report

Newspaper Advertisement

Confirmation Regarding Crit...

Clarification Letter

Compliance Certificate

Compliance Certificate Subm...

Price Clarification

Compliance Certificate Subm...

Compliance Certificate Subm...

Newspaper Advertisement

Dispatch of Postal Ballot N...

Certificate Submission

Newspaper Publication

Certificate Submission

Collaboration with Chhattis...

Equity Offerings

Financial Statements

Investor Meetings

Newspaper Publication

Financial Statements Public...

External Links:

Data:

Indo Us Bio-Tech Ltd announced compliance under Regulation 74(5) of SEBI for dematerialization of securities for the quarter ended December 31, 2024, confirming all securities were listed and processed accordingly.

AI Assistant

Indo US Bio-Tech Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.